Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -100.00%-5 | -32.10%369.72K | 161.85%544.55K | 122.08%207.96K | -20.52%93.64K | 75.16%117.82K | -23.02%67.26K | 137.41%87.38K | -355.83%-233.6K | |
| Revenue from customers | ---- | ---- | -12.41%113.88K | 59.05%130K | 87.28%81.74K | -6.39%43.64K | -30.69%46.62K | -23.02%67.26K | --87.38K | ---- |
| Other cash income from operating activities | ---- | -100.00%-5 | -38.28%255.85K | 228.42%414.54K | 152.45%126.23K | -29.77%50K | --71.2K | ---- | ---- | -355.83%-233.6K |
| Cash paid | -96.09%-1.98M | 23.04%-1.01M | -106.14%-1.31M | -8.27%-635.08K | 22.44%-586.56K | 16.79%-756.27K | -38.96%-908.84K | -21.12%-654.04K | -26.74%-539.97K | 46.50%-426.05K |
| Payments to suppliers for goods and services | -96.09%-1.98M | 23.04%-1.01M | -106.14%-1.31M | -8.27%-635.08K | 22.44%-586.56K | 16.79%-756.27K | -38.96%-908.84K | -21.12%-654.04K | -26.74%-539.97K | 46.50%-426.05K |
| Direct interest paid | 14.71%-10.57K | -84.16%-12.39K | ---6.73K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest received | 23.13%29.93K | -60.56%24.31K | 443.96%61.65K | 196.83%11.33K | -88.30%3.82K | -46.55%32.62K | -31.50%61.03K | -28.69%89.09K | -9.85%124.95K | -52.91%138.59K |
| Operating cash flow | -96.49%-1.96M | -12.56%-995.61K | -1,016.80%-884.52K | 78.87%-79.2K | 40.51%-374.78K | 13.70%-630K | -46.68%-729.99K | -51.90%-497.68K | 37.12%-327.64K | 9.93%-521.06K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 34.51%-1.45M | 6.11%-2.22M | -840.55%-2.36M | 83.00%-251.4K | -32.86%-1.48M | -101.82%-1.11M | 10.43%-551.43K | 30.22%-615.65K | 81.19%-882.24K | -208.65%-4.69M |
| Capital expenditure reported | 49.28%-1.19M | -0.59%-2.35M | -568.82%-2.34M | 60.17%-349.9K | 21.06%-878.56K | -45.00%-1.11M | -25.69%-767.52K | 29.90%-610.65K | -122.84%-871.14K | 59.75%-390.93K |
| Net PPE purchase and sale | -35,707.16%-259.96K | 92.87%-726 | -110.18%-10.18K | --100K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net intangibles purchas and sale | ---- | --147.19K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | -844.00%-14.16K | 99.75%-1.5K | ---600K | ---- | ---- | 54.95%-5K | 99.75%-11.1K | -185.26%-4.37M |
| Net other investing changes | ---- | 11.72%-12.5K | -844.00%-14.16K | ---1.5K | ---- | ---- | --216.08K | ---- | ---- | --72.9K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 34.51%-1.45M | 6.11%-2.22M | -840.55%-2.36M | 83.00%-251.4K | -32.86%-1.48M | -101.82%-1.11M | 10.43%-551.43K | 30.22%-615.65K | 81.19%-882.24K | -208.65%-4.69M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 593.54%8.96M | -58.50%1.29M | 110.43%3.11M | 92.66%1.48M | -44.59%767.63K | 190.71%1.39M | 476.52K | 132.70%1.32M | -3,042.83%-4.03M | |
| Net common stock issuance | 560.15%9.04M | -56.44%1.37M | 112.51%3.14M | 92.66%1.48M | -44.59%767.63K | 190.71%1.39M | --476.52K | ---- | 132.70%1.32M | -57,158.02%-4.03M |
| Net other financing activities | 47.68%-81.21K | -152.21%-155.22K | ---61.54K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 593.54%8.96M | -58.50%1.29M | 110.43%3.11M | 92.66%1.48M | -44.59%767.63K | 190.71%1.39M | --476.52K | ---- | 132.70%1.32M | -3,042.83%-4.03M |
| Net cash flow | ||||||||||
| Beginning cash position | -83.75%373.44K | -5.98%2.3M | 89.43%2.44M | -46.03%1.29M | -13.01%2.39M | -22.65%2.75M | -23.86%3.55M | 2.35%4.67M | -51.63%4.56M | 62.07%9.42M |
| Current changes in cash | 388.28%5.55M | -1,305.89%-1.92M | -111.92%-136.86K | 205.77%1.15M | -203.62%-1.09M | 55.57%-357.58K | 27.70%-804.9K | -1,138.89%-1.11M | 101.16%107.17K | -355.93%-9.24M |
| Effect of exchange rate changes | ---- | 100.05%5 | -273.96%-9.16K | 136.50%5.27K | -360,725.00%-14.43K | -99.10%4 | --443 | ---- | ---- | ---- |
| End cash Position | 1,485.31%5.92M | -83.75%373.44K | -5.98%2.3M | 89.43%2.44M | -46.03%1.29M | -13.01%2.39M | -22.65%2.75M | -23.86%3.55M | 2,400.27%4.67M | -98.02%186.6K |
| Free cash from | -1.79%-3.41M | -3.57%-3.35M | -653.88%-3.23M | 65.76%-429.1K | 28.09%-1.25M | -16.39%-1.74M | -35.11%-1.5M | 7.54%-1.11M | -31.45%-1.2M | 52.60%-911.99K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |